-

Atropos Health Delivers Greater Access to Real-World Evidence Through Google Cloud Marketplace

Atropos Health’s evidence-generation solutions and real-world data in the Atropos Evidence Network give customers the ability to access more personalized, real-world evidence with Google Cloud

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, today announced its availability on Google Cloud Marketplace, providing customers with increased access to relevant and timely RWE within their Google Cloud environment. Atropos Health's Artificial Intelligence (AI)-powered solutions help healthcare and life science organizations improve patient outcomes, design clinical trials, reduce time and costs for data analysis, and optimize treatment plans at the point and pace of care.

Google Cloud Marketplace lets users quickly deploy functional software packages that run on Google Cloud and allows customers to easily start up a familiar software package with services like Google Cloud Compute Engine or Cloud Storage, with no manual configuration required.

Google Cloud Marketplace customers can access Atropos Health’s portfolio of evidence-generation tools through the federated installation of GENEVA OS® in their internal cloud data environment. Customers gain access to Alexandria®, a collection of over 100,000 existing studies, including active clinical trial designs, to answer clinical questions. The existing studies in Alexandria can also be rerun on local data, generating novel new content. Customers can also choose ChatRWD®, the first generative AI application to deliver observational studies on healthcare data in minutes - a breakthrough in rapid real-world evidence.

“Atropos Health's availability enables an agent-driven workflow for evidence generation directly into the hands of researchers and clinicians," said Dr. Brigham Hyde, Co-founder and CEO of Atropos Health. “Customers can now deploy autonomous agents that generate evidence on demand and this agent-driven workflow is the key to unlocking personalized medicine at scale.”

“Bringing GENEVA OS® to Google Cloud Marketplace will help customers quickly deploy, manage, and grow the real-world evidence operating system on Google Cloud's trusted, global infrastructure," said Dai Vu, Managing Director, Marketplace & ISV GTM Programs at Google Cloud. “Atropos Health can now securely scale and support customers on their digital transformation journeys.”

For more information on Atropos Health, please visit atroposhealth.com or Google Cloud Marketplace.

About Atropos Health

Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or follow on X (Twitter) @AtroposHealth.

Contacts

Alex Millman
atropos@solcomms.co

Atropos Health


Release Versions

Contacts

Alex Millman
atropos@solcomms.co

More News From Atropos Health

Atropos Health Announces Key New Hires to Scale High Quality Evidence Utilization in the Healthcare Ecosystem

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), announced the addition of two new hires to the leadership team, including the company's first Chief Technology Officer and Chief Financial Officer. The addition of these two team members expands the companies’ domain knowledge across the healthcare ecosystem including telehealth, payers and big tech. To further enhance the company's mission to clos...

Atropos Health Named to the 2026 New York Digital Health 100

NEW YORK--(BUSINESS WIRE)--Atropos Health announced today that it has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in conjunction with the 2026 New York Healthcare Innovation Report, which analyzes key investment trends, market dynamics, and opportunities shaping the digital health ecosystem. Now in i...

Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced the availability of Commercial Analytics solutions for life science leaders. This is an extension to the already growing number of solutions available to life science companies to accelerate decision making across the Real World Data, R&D, HEOR/Medical, and Brand use cases. The solution leverages the speed and accuracy of ChatRW...
Back to Newsroom